X hits on this document

PDF document

Securities Exchange Act of 1934 Rule 14d-11; Rule 14d-11(f) Rule 14d-10(a)(2) Rule 14e-1(b) - page 4 / 13

38 views

0 shares

0 downloads

0 comments

4 / 13

LLP

FRANKFURTAM MAlN CHl?lSTOF ' $ 0 ,DRVANDZI?

"cc,"5k,,>"ALr MLMOL" O r r i i L W ,an"

UI?

r ! L L ~01.l FR IBOLD

"CCKT9ANIYILT

I

rno

m P " W or OnU*ILLcs

__

DR WFRNER MLlCl?

MAlN TOWER NEUE MAINZER STRASSE 52 603 1 1 FRANKFURT AM MAlN

  • -

    t 49 (69) 97 103-0

FACSIMILE + 49 (69) 97103-199

WWW CLEARYGOTTLIEB COM

Dl? SlLr'HAN r nARTtIFILMESS ,,LCH,~A,<WAL MCMLiiX O+ , M i N I W "ORK "An

ANCIRES

D F LA CliLJZ

nona*oo ,xnrcNi,,,a, AT LAW ,,,sn> nL#cNoan,,,,c "a*% h"OPNLI h>C,<"CR A,dD NLV, or,,,c "OX,<

WARCI A GREENBLI2G

"nOllPILY i r L,IW MFM"CR orT!4c NC," ,119A1 ""RK

UN,

DR KLAUS IIIEHMER

FRLcMrsAN,"ALr WcMnc" o r T,,C NC>"

.,O,,K

"a,*

HANNO S l ~ L l ? l ~ l C H

PFCYiSlliWALT

COLOGNE DR W0LI:GANG

KNAI'I'

XFCYTSANIVACT Awmiihu -**TAU

DL OPU<LLLLI

Ti4OMAS M BLJHL

"CC,"5A,d\"AL, AVOCAT A U nA",,EAu DL ,,A,,,+

,IICYI9,1NIYALT

I'liill t l R

DIRK SIIIROFDFR

ncc,"sAN>,,ALT

DR GABRICLC A171LL-HACHLR

JOHN I'ALLNBERG

"ICIITDAR~,~*LTIN

NEW

YORK

.

WASHINGTON, DC

.

PARIS

.

BRUSSE1.S

Mr,""cn or,,,c

NC,"

"0°K

W,\H

m n P N n AT L%",U51// MLML\L,4 0, ,HL NW, ""Plk n,>R

LONDON R O M E . MILAN .

MOSCOW. COLOGNE*

.

HONG KONG

.

BElJlNG

DR THOMAS KOPP

RbCHrsANwAL,

UR ROMINA POL1 FY

"iCl"ilNWdLTl,l

DR

I F D A N I C L W L Y C I E *

Dl< MICHALL UREMS

"ICIITLAlllYILT MLMOL" or T i i i

>TLU,,,,,I*Ar, NLW YUitK "I"

XrCI,rsANIV"LT

MLML,L,<

"b

IHL

,Ab$"

"

<>WK

RA"

BY E-MAIL AND BY HAND

Brian V. Brel~eny,Esq. Chief, Office of Mergers and Acquisitions Division of Corporation Finance

Christina E. Chalk, Esq. Special Counsel, Office of Mergers and Acquisitioil Division of Corporation Finance

Securities and Exchange Conlnlission 100 F Street, N.W. Washington, D.C. 20549

Ladies and Gentlemen:

We are writing on behalf of our clients Bayer Aktiengesellschaft, a Gerillan stock corporation ("Bayer"), and Dritte BV GmbH (the "Offeror" and, together with Bayer, the "Baycr Entities").

As of Septcinber 8,2006, the Offeror owned approxinlately 95.112% of thc ordinary shares wit11no par value (the "Ordinary Sl~ares"),includiilg Ordiilary Shares represented by American Depositary Shares (the "ADSs" and, together with the Ordinary Shares, the "Shares"), of Schering Aktiengesellschaft, a Gerillan stock corporation ("Scl~erii~g")outstanding as of that date (excluding treasury shares). The Offeror acquired these Ordinary Shares pursuant to, outside of and following the earlier voluntary tender offer (the "~oluiltaryTender Offer") for the Shares of Schering described in letters of Latl~aill& Watkins liled wit11 the Securities and Exchange Con~nlissio (the "Commission") on April 12, 2006 and June 12, 2006 and in the Offer Docunlent filed as Exhibit (a)(l)(A) to the Schedule TO filed by the Bayer Entities on April 13, 2006, as ailleilded. The Voluntary Tender Offer concluded on July 6,2006.

  • *

    COLOGNE OFFICE

+49 (221 ) 80040 0

FACSIMILE +49 (221 ) 80040-1 99

Document info
Document views38
Page views38
Page last viewedSat Dec 03 01:12:21 UTC 2016
Pages13
Paragraphs175
Words6245

Comments